Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124781034 | 12478103 | 4 | F | 20160521 | 20160823 | 20160617 | 20160901 | EXP | PHEH2016US014825 | SANDOZ | 70.42 | YR | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124781034 | 12478103 | 1 | SS | VOTRIENT | PAZOPANIB HYDROCHLORIDE | 1 | Oral | 800 MG, QD | Y | UNKNOWN | 0 | 800 | MG | QD | |||||
| 124781034 | 12478103 | 2 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 73288 | ||||||||||
| 124781034 | 12478103 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | EXTENDED RELEASE TABLET | ||||||
| 124781034 | 12478103 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 600 UNK, UNK | U | 0 | 600 | MG | EXTENDED RELEASE TABLET | ||||||
| 124781034 | 12478103 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | TABLET | ||||||
| 124781034 | 12478103 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | U | 0 | ||||||||||
| 124781034 | 12478103 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 124781034 | 12478103 | 8 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Unknown | U | 0 | CAPSULE | |||||||||
| 124781034 | 12478103 | 9 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Unknown | U | 0 | ORAL SOLUTION | |||||||||
| 124781034 | 12478103 | 10 | C | BENADRYL /00647601/ | CAMPHORDIPHENHYDRAMINEINC OXIDE | 1 | Unknown | U | 0 | ||||||||||
| 124781034 | 12478103 | 11 | C | OXYCODONE | OXYCODONE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 124781034 | 12478103 | 12 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | U | 0 | ORAL SUSPENSION | |||||||||
| 124781034 | 12478103 | 13 | C | CLONIDINE. | CLONIDINE | 1 | Transdermal | 0.1 MG/H, QW | U | 0 | /wk | ||||||||
| 124781034 | 12478103 | 14 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | CAPSULE | ||||||
| 124781034 | 12478103 | 15 | C | PROCHLORPERAZINE MALEATE. | PROCHLORPERAZINE MALEATE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | TABLET | ||||||
| 124781034 | 12478103 | 16 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | TABLET | ||||||
| 124781034 | 12478103 | 17 | C | XANAX | ALPRAZOLAM | 1 | Unknown | 0.5 MG, UNK | U | 0 | .5 | MG | TABLET | ||||||
| 124781034 | 12478103 | 18 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 0.1 ML, UNK | U | 0 | .1 | ML | SPRAY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124781034 | 12478103 | 1 | Metastatic renal cell carcinoma |
| 124781034 | 12478103 | 2 | Hypertension |
| 124781034 | 12478103 | 3 | Product used for unknown indication |
| 124781034 | 12478103 | 5 | Product used for unknown indication |
| 124781034 | 12478103 | 6 | Product used for unknown indication |
| 124781034 | 12478103 | 7 | Product used for unknown indication |
| 124781034 | 12478103 | 8 | Product used for unknown indication |
| 124781034 | 12478103 | 9 | Product used for unknown indication |
| 124781034 | 12478103 | 10 | Product used for unknown indication |
| 124781034 | 12478103 | 11 | Product used for unknown indication |
| 124781034 | 12478103 | 12 | Product used for unknown indication |
| 124781034 | 12478103 | 13 | Product used for unknown indication |
| 124781034 | 12478103 | 14 | Product used for unknown indication |
| 124781034 | 12478103 | 15 | Product used for unknown indication |
| 124781034 | 12478103 | 16 | Product used for unknown indication |
| 124781034 | 12478103 | 17 | Product used for unknown indication |
| 124781034 | 12478103 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124781034 | 12478103 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124781034 | 12478103 | Abdominal pain | |
| 124781034 | 12478103 | Alanine aminotransferase increased | |
| 124781034 | 12478103 | Anaemia | |
| 124781034 | 12478103 | Aspartate aminotransferase increased | |
| 124781034 | 12478103 | Back pain | |
| 124781034 | 12478103 | Blood alkaline phosphatase increased | |
| 124781034 | 12478103 | Cough | |
| 124781034 | 12478103 | Diarrhoea | |
| 124781034 | 12478103 | Dyspnoea exertional | |
| 124781034 | 12478103 | Ecchymosis | |
| 124781034 | 12478103 | Epistaxis | |
| 124781034 | 12478103 | Fatigue | |
| 124781034 | 12478103 | Flank pain | |
| 124781034 | 12478103 | Headache | |
| 124781034 | 12478103 | Hepatic enzyme increased | |
| 124781034 | 12478103 | Hyperbilirubinaemia | |
| 124781034 | 12478103 | Hypertension | |
| 124781034 | 12478103 | Jaundice | |
| 124781034 | 12478103 | Malignant ascites | |
| 124781034 | 12478103 | Malignant neoplasm progression | |
| 124781034 | 12478103 | Metastases to chest wall | |
| 124781034 | 12478103 | Metastases to liver | |
| 124781034 | 12478103 | Oedema | |
| 124781034 | 12478103 | Pain | |
| 124781034 | 12478103 | Pneumonia | |
| 124781034 | 12478103 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124781034 | 12478103 | 1 | 20160421 | 20160516 | 0 |